NICE guidance on aflibercept for treatment of metastatic colorectal cancer

被引：0
作者：
Elsada, Ahmed [1 ]
George, Elisabeth [1 ]
Adler, Amanda [1 ]
机构：
[1] Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 06期
关键词：
D O I：
10.1016/S1470-2045(14)70133-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：561 / 562
页数：2
相关论文
共 5 条
  • [1] [Anonymous], 2009, Appraising life-extending, end of life treatments
  • [2] NICE, 2014, NICE TECHN APPR GUID
  • [3] NICE, 2013, MAN SUBM AFL ZALTR T
  • [4] Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
    Van Cutsem, Eric
    Tabernero, Josep
    Lakomy, Radek
    Prenen, Hans
    Prausova, Jana
    Macarulla, Teresa
    Ruff, Paul
    van Hazel, Guy A.
    Moiseyenko, Vladimir
    Ferry, David
    McKendrick, Joe
    Polikoff, Jonathan
    Tellier, Alexia
    Castan, Remi
    Allegra, Carmen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) : 3499 - 3506
  • [5] Wade R., 2013, AFLIBERCEPT COMBINAT
1